News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Become an expert to evaluate SSH aspects in the Cluster 5 calls
The European Commission is encouraging SSH experts to register in the European Commission’s expert database to evaluate the SSH aspects (Social Sciences and Humanities) of R&I actions under the Cluster 5 work programme of Horizon Europe.
If you are interested, make sure to register before 4 October 2024!
- Step 1: Register to the European Commission's expert database.
- Step 2: Complete this form.
More information on becoming an evaluator of EU Research projects is available here.
Related News
|
2024-12-16
|
6 days ago |
EIT urban mobility: open call for financial support to start-ups |
|
2024-12-10
|
1 week ago |
STARHAUS Open Calls on Open Innovation and Creativity |
|
2024-12-04
|
2 weeks ago |
The Strategic Technologies for Europe Platform - the STEP funding dashboard with open... |
|
2024-11-14
|
1 month ago |
Update on the 2025 call topics for cluster 5 |
|
2024-11-05
|
1 month ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
|
2024-10-07
|
2 months ago |
Booklet “Standing up for democracy” published |
|
2024-09-20
|
3 months ago |
Database on transnational and virtual access to research infrastructures for all scie... |
|
2024-09-18
|
3 months ago |
Cluster 5 (D3&D4) calls are now open for submission |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1504 articles available search in articlesHorizon Europe Digital Europe Defence
Happy holidays!
The NCP Flanders team wishes you happy holidays and all the best for 2025! Please note that our offices are closed between Christmas and new year. read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
